Survey of oncology providers on psychosocial distress

描述(由申请人提供)： 概述和背景：此R03应用程序建议调查肿瘤学提供者，了解他们筛查心理社会困境的做法。尽管国家综合癌症网络(NCCN)指南已经发布了近五年，但没有关于其使用程度的数据。如果要在现有的肿瘤学治疗系统内改善癌症患者的心理社会护理的努力取得成功，关于当前常规做法的数据至关重要。基于研究表明，肿瘤提供者的危难识别能力很差，这项调查重点是筛查危难，这是NCCN指南的切入点。通过检查这一关键时刻，可以根据肿瘤学家报告的做法，进一步努力改善心理社会护理。 主要目的：这项研究的目标是在全国范围内对肿瘤学家进行一次关于使用NCCN指南筛查癌症患者痛苦的调查。这份申请是由两名初级调查人员提交的，他们是皮尔博士和穆里尔博士，他们将接受科恩布利斯博士对这项研究的指导。 方法：在一个简短的启动阶段，我们将收集调查问卷的可接受性数据，从马萨诸塞州的10位肿瘤学家那里获得对该仪器的系统反馈。如有需要，我们将对问卷进行修改。在第一年，我们将通过电子邮件将调查问卷分发给马萨诸塞州400多名肿瘤学家，他们是美国临床肿瘤学会(ASCO)的成员。在第二年，我们将把调查范围扩大到从ASCO国家会员名录中随机挑选的1000名肿瘤学家。将使用调查每个项目的频率分布来分析数据。 奖励机制：该项目采用R-03小额资助机制，遵循“癌症控制中的行为研究小额资助”的计划公告。这一机制以初级研究人员和研究为目标，这些研究将“促进在行为癌症控制研究方面拥有高水平研究专长的全国科学家队伍的增长。”这项调查的数据将使研究人员能够继续他们的癌症护理模式的研究计划，该模式包括癌症痛苦筛查以及开发和测试强调的循证干预措施。它还将以较低的成本评估NCCN危难筛查指南的使用和效用，如有必要，提供数据，以证明将危难筛查扩展到常规癌症护理的进一步努力的合理性。

DESCRIPTION (provided by applicant): Overview and Background: This R03 application proposes to survey oncology providers about their practices of screening for psychosocial distress. Although the National Comprehensive Cancer Network (NCCN) guidelines have been published for almost five years, there is no data on the extent of their use. If efforts at improving the psychosocial care of cancer patients within existing oncology treatment systems are to be successful, data on current routine practices are critically important. Building on research that demonstrates that distress recognition by oncology providers is poor, this survey focuses on screening for distress, the entry point of the NCCN guidelines. By examining this crucial juncture, further efforts at improving the psychosocial care can be tailored to the reported practices of oncologists. Primary Aim: The goal of this study to administer a nation-wide survey of oncologists on the use of the NCCN guidelines for screening for distress in cancer patients. This application is being submitted by two junior investigators, Drs. Pirl and Muriel, who will receive the mentorship of Dr. Kornblith for the study. Methods: During a brief start-up phase, we will gather acceptability data on the survey questionnaire by obtaining systematic feedback on the instrument from ten oncologists in Massachusetts. As needed, we will revise the questionnaire. In year 1, we will distribute the survey by email to over 400 oncologists in Massachusetts who are members of the American Society of Clinical Oncology (ASCO). In year 2, we will extend the survey to 1,000 randomly selected oncologists from the national membership directory of ASCO. Data will be analyzed using frequency distributions on each item of the survey. Mechanism of award: This project uses the R-03, small grant mechanism, following the program announcement for "Small grants for behavioral research in cancer control." This mechanism targets junior investigators and research that will "facilitate the growth of a nationwide cohort of scientists with a high level of research expertise in behavioral cancer control research." The data from this survey will allow the investigators to continue their program of research on models of cancer care that integrate screening for distress in cancer and developing and testing evidence-based interventions that emphasize. It will also, with a low cost, allow for the evaluation of the use and utility of the NCCN guidelines for distress screening, providing data, if necessary, to justify further efforts to extend distress screening into regular cancer care.